NPPES file of Aug 9, 2026

Anteneh A. Tesfaye, MD

Hematology & Oncology Physician · Washington, DC

Anteneh A. Tesfaye, MD is a hematology & oncology physician with a practice address in Washington, District of Columbia, and NPI 1003128810, issued on Jul 9, 2010. Check the license on the District of Columbia Board of Medicine; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1003128810
Name
Anteneh A. Tesfaye
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
4301095841 MI
Self-reported in NPPES; status is on the state search
Practice location
110 Irving St NW Ste C2151, Washington, DC 20010
Phone
(202) 877-6998
Enumerated
Jul 9, 2010
Record last updated
Nov 19, 2021 (not updated in 5 years: call before relying on the address or phone)
Fax
(202) 877-8909
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Anteneh A. Tesfaye in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersDistrict of Columbia Board of MedicineCheck the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the District of Columbia license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

60% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

352 Medicare Part D claims for 74 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims. 36 claims were for opioids.

  1. Anteneh Tesfaye352
  2. Specialty average877

Most prescribed

  1. Lenvima25 claims
  2. Ondansetron Odt22 claims
  3. Everolimus21 claims
  4. Eliquis20 claims
  5. Dexamethasone13 claims
  6. Hydrocodone-Acetaminophen13 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $4,800.48

25 payments; by number, the most common kind was food and beverage; the largest payer was Exelixis Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Anteneh Tesfaye$4,800.48
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Anteneh A. Tesfaye among 81 hematology & oncology physician records in District of Columbia

Anteneh A. Tesfaye, MD is one of 81 hematology & oncology physician records with a practice address in District of Columbia. 74% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2010, is newer than 60% of them.

  • NPI issued2010 · 60% of these records are older, 35% newer
  • In a Medicare fileYes · 74% of these records are
  • In the CMS Doctors and Clinicians fileNo · 57% of these records are
  • Record last updated2021 · 70% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a District of Columbia practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in District of Columbia

There are 81 hematology & oncology physician records in District of Columbia.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Anita Aggarwal, DOWashington, DC 200101891740726
  2. Puja Arora, M.D.Washington, DC 200101154766533
  3. Joseph Catlett, MDWashington, DC 200101295788263
  4. Pia Herbolsheimer, MDWashington, DC 200101174761795
  5. Natasha Jain, M.B.B.SWashington, DC 200101578981445
  6. Avani Mohapatra, MDWashington, DC 200101285879171
  7. Maria Nunes, MDWashington, DC 200101679740252
  8. David Perry, MDWashington, DC 200101992752992

Common questions

What is Anteneh A. Tesfaye, MD's NPI number?

Anteneh A. Tesfaye, MD's National Provider Identifier (NPI) is 1003128810, issued on Jul 9, 2010. An NPI identifies a provider in billing; it is not a license.

Where is Anteneh A. Tesfaye, MD located?

The NPPES record lists a practice address at 110 Irving St NW Ste C2151, Washington, DC, 20010. Phone: (202) 877-6998. Providers update this record themselves, so call before visiting.

How can I verify Anteneh A. Tesfaye, MD's license?

Search the District of Columbia Board of Medicine at https://dchealth.dc.gov/bomed. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Anteneh A. Tesfaye, MD prescribe under Medicare Part D?

In 2024, Anteneh A. Tesfaye, MD had 352 Medicare Part D claims for 74 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.